NCT07398898 Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients
| NCT ID | NCT07398898 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Warsaw |
| Condition | Dental Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2026-03-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates whether new audiovisual technologies can help reduce anxiety and stress experienced by adult patients during dental procedures. Dental fear and anxiety are common barriers to receiving proper oral care. This randomized controlled trial aims to explore whether the use of specific devices-augmented reality (AR) glasses and noise-cancelling (ANC) headphones-can improve patient comfort and decrease physiological signs of stress during dental treatment. Participants in this study will undergo a standard dental procedure. In addition, they will be randomly assigned to one of three groups: a control group (no audiovisual intervention), a group using ANC headphones that play relaxing music during the procedure, or a group using AR glasses that display relaxing visual scenes along with the same music. Before the procedure, each participant will complete a psychological questionnaire (STAI) to assess their level of anxiety. During the procedure, physiological stress will be monitored using sensors that track parameters such as skin conductance (GSR) and heart rate. After the treatment, patients will be asked to rate their pain level and describe their experience with or without the audiovisual intervention. The goal is to better understand the effectiveness of non-pharmacological methods in reducing anxiety and stress in adult dental patients. Participation in the study is entirely voluntary and will not affect the quality or availability of dental care. Patients may withdraw at any time without consequences. The study also collects basic demographic information and patient feedback to evaluate potential factors that may influence anxiety levels. By testing new immersive tools such as AR glasses and ANC headphones in a real clinical setting, this research may contribute to improving patient well-being and enhancing the dental care experience.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Qualified for one of the following dental procedures: supragingival scaling, curettage, tooth extraction, or caries cavity preparation and restoration * Provided written informed consent * Agreed to random allocation to one of the study groups * Able to understand and complete the STAI questionnaire and VAS pain scale Exclusion Criteria: * Acute dental pain at the time of the procedure * Teeth qualified for resection * Pregnancy * Diagnosis of cerebral palsy * Epilepsy with seizures in the past 6 months * Use of hearing aids * Severe vision impairment * Non-cooperative behavior or inability to understand the study questionnaires * Absence on the scheduled procedure date
Contact & Investigator
Jan Kowalski, Associate Professor, MD, PhD
PRINCIPAL INVESTIGATOR
Medical University of Warsaw
Frequently Asked Questions
Who can join the NCT07398898 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dental Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07398898 currently recruiting?
Yes, NCT07398898 is actively recruiting participants. Contact the research team at jakub.bereziewicz@wum.edu.pl for enrollment information.
Where is the NCT07398898 trial being conducted?
This trial is being conducted at Warsaw, Poland.
Who is sponsoring the NCT07398898 clinical trial?
NCT07398898 is sponsored by Medical University of Warsaw. The principal investigator is Jan Kowalski, Associate Professor, MD, PhD at Medical University of Warsaw. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.